Akèy › Maladi otoim › Pennsylvania › Philadelphia
Etid klinik pou Maladi otoim nan Philadelphia, PA
16 etid pou Maladi otoim ap chèche patisipan nan sit nan ak bò kote Philadelphia (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Autoimmunity After Checkpoint Blockade
Ap rekriteEtid obsèvasyon
- University of Pennsylvania - Abramson Cancer Center, Philadelphia
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Ap rekriteFaz 3
- Perelman Center for Advanced Medicine (PCAM) Hospital of The University of Pennsylvania Penn Blood Disorders Program, Philadelphia
- Lewis Katz School of Medicine at Temple University, Philadelphia
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
Ap rekriteFaz 2/3
- Children's Hospital of Philadelphia - Accepting Young Adult and Juvenile Patients, Philadelphia
A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis
Ap rekriteFaz 2
- Fox Chase Cancer Center- Temple BMT, Philadelphia
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Ap rekriteFaz 3
- Perelman Center for Advanced Medicine (PCAM) Hospital of The University of Pennsylvania Penn Blood Disorders Program, Philadelphia
- Lewis Katz School of Medicine at Temple University, Philadelphia
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
Ap rekriteFaz 3
- GSK Investigational Site, Philadelphia
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
Ap rekriteFaz 1/2
- Children's Hospital of Philadelphia, Philadelphia
Abatacept for the Treatment of Giant Cell Arteritis
Ap rekriteFaz 3
- University of Pennsylvania, Philadelphia
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
Ap rekriteFaz 3
- The Children's Hospital of Philadelphia, Philadelphia
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
Ap rekriteFaz 2/3
- Thomas Jefferson University Hospital, Philadelphia
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Ap rekriteEtid obsèvasyon
- Children's Hospital of Philadelphia, Philadelphia
- Nemours - Alfred I. duPont Hospital for Children, Brandywine · 21 mi lwen
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
Ap rekriteFaz 1/2
- University of Pennsylvania, Philadelphia
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Ap rekriteFaz 1
- Jefferson Einstein Hospital Philadelphia, Philadelphia
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
Ap rekriteFaz 1
- Temple University Hospital, Philadelphia
Central Vein Sign in Multiple Sclerosis Extension Study
Ap rekrite
- University of Pennsylvania, Philadelphia
X-linked Moesin Associated Immunodeficiency
Ap rekriteEtid obsèvasyon
- Perelman School of medecine, Philadelphia
Etid Maladi otoim nan lòt vil
- Houston, TX21 etid
- Washington, DC19 etid
- New York City, NY19 etid
- Durham, NC15 etid
- Boston, MA13 etid
- Chicago, IL12 etid
- Los Angeles, CA12 etid
- Dallas, TX9 etid
- Atlanta, GA8 etid
- Portland, OR8 etid
- Milwaukee, WI8 etid
- Cleveland, OH8 etid
Lòt etid nan Philadelphia
- Kansè (tout kalite)59 etid
- Kansè nan tete56 etid
- Kansè Poumon ki pa ti selil51 etid
- Kansè Metastatik46 etid
- Kansè pwostat44 etid
- Kansè kolorektal44 etid
- Kansè ovè44 etid
- Kansè poumon36 etid
- Leksemi mieloïd egi34 etid
- Ensifizyans kadyak31 etid
- Kansè Endomèt28 etid
- Depresyon26 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.